Chemoinformaics analysis of VIOLAXANTHIN-LINEOLEATE-LINOLENATE
| Molecular Weight | 1123.74 | nRot | 39 |
| Heavy Atom Molecular Weight | 1008.83 | nRig | 32 |
| Exact Molecular Weight | 1122.86 | nRing | 4 |
| Solubility: LogS | -8.946 | nHRing | 2 |
| Solubility: LogP | 17.29 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 196 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 82 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 114 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 76 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 207.746 |
| nHD | 0 | BPOL | 123.046 |
| QED | 0.02 |
| Synth | 6.202 |
| Natural Product Likeliness | 1.074 |
| NR-PPAR-gamma | 0.734 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.031 |
| Pgp-sub | 0.209 |
| HIA | 0.043 |
| CACO-2 | -4.635 |
| MDCK | 0.00000253 |
| BBB | 0.002 |
| PPB | 1.18639 |
| VDSS | 5.479 |
| FU | 0.00397574 |
| CYP1A2-inh | 0.012 |
| CYP1A2-sub | 0.108 |
| CYP2c19-inh | 0.118 |
| CYP2c19-sub | 0.893 |
| CYP2c9-inh | 0.068 |
| CYP2c9-sub | 0.947 |
| CYP2d6-inh | 0.314 |
| CYP2d6-sub | 0.927 |
| CYP3a4-inh | 0.933 |
| CYP3a4-sub | 0.934 |
| CL | 4.77 |
| T12 | 0.001 |
| hERG | 0.567 |
| Ames | 0.13 |
| ROA | 0.021 |
| SkinSen | 0.998 |
| Carcinogencity | 0.929 |
| EI | 0.007 |
| Respiratory | 0.165 |
| NR-Aromatase | 0.966 |
| Antiviral | Yes |
| Prediction | 0.879614 |